๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B

โœ Scribed by Shogo Ohkoshi; Akira Yoshimura; Satoshi Yamamoto; Masahiko Yano; So Kurita; Kazuhide Yamazaki; Yo-hei Aoki; Satoshi Yamagiwa; Hiroto Wakabayashi; Motoya Sugiyama; Tohru Takahashi; Tohru Ishikawa; Yasunobu Matsuda; Takafumi Ichida; Tomoteru Kamimura; Yutaka Aoyagi

Publisher
Springer-Verlag
Year
2008
Tongue
English
Weight
783 KB
Volume
2
Category
Article
ISSN
1936-0533

No coin nor oath required. For personal study only.

๐Ÿ“œ SIMILAR VOLUMES

The development of cirrhosis in patients
The development of cirrhosis in patients with chronic type B hepatitis: A prospective study
โœ Yun-Fan Liaw; Dar-In Tai; Chia-Ming Chu; Tong-Jong Chen ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 500 KB ๐Ÿ‘ 1 views

The incidence and contributing factors of cirrhosis developing in patients with chronic type B hepatitis were assessed prospectively in 684 clinicopathologically verified patients, of which 509 were HBeAg positive and 175 were anti-HBe positive at entry into the study. During an average follow-up pe

Mutations associated with the therapeuti
Mutations associated with the therapeutic efficacy of adefovir dipivoxil added to lamivudine in patients resistant to lamivudine with type B chronic hepatitis
โœ Kazuyoshi Ohkawa; Tetsuo Takehara; Michio Kato; Aimi Kanada; Matsuo Deguchi; Mas ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 269 KB

## Abstract Factors influencing the therapeutic efficacy of adefovir dipivoxil added to continuing lamivudine have not been elucidated in lamivudineโ€resistant patients with type B chronic hepatitis. The viral mutations influencing the efficacy of treatment with adefovir dipivoxil were investigated

Soluble CD14 levels are increased and in
Soluble CD14 levels are increased and inversely correlated with the levels of hepatitis B surface antigen in chronic hepatitis B patients
โœ Sophia Steyaert; Peter Vanlandschoot; Hans Van Vlierberghe; Helmut Diepolder; Ge ๐Ÿ“‚ Article ๐Ÿ“… 2003 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 219 KB ๐Ÿ‘ 1 views

## Abstract Because it was observed recently that yeastโ€derived recombinant HBsAg interacts in a lipopolysaccharide binding proteinโ€dependent manner with CD14 expressed on human monocytes, we investigated whether HBsAg influences the serum levels of sCD14, lipopolysaccharide binding protein and Cโ€r

Hepatitis B virus DNA in serum and liver
Hepatitis B virus DNA in serum and liver is commonly found in chinese patients with chronic liver disease despite the presence of antibodies to HBsAg
โœ Yong-Yuan Zhang; Bengt Gรถran Hansson; Lin Sheng Kuo; Anders Widell; Erik Nordenf ๐Ÿ“‚ Article ๐Ÿ“… 1993 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 770 KB

## Republic of China Sera from 410 patients from the Wuhan area in the central part of China with the diagnosis of chronic liver disease were analyzed for markers of hepatitis B, C and D virus infections. All sera, plus liver biopsy specimens from 188 of the patients, were also tested for hepatiti

Association of intrahepatic cccDNA reduc
Association of intrahepatic cccDNA reduction with the improvement of liver histology in chronic hepatitis B patients receiving oral antiviral agents
โœ Pin-Nan Cheng; Wen-Chun Liu; Hung-Wen Tsai; I-Chin Wu; Ting-Tsung Chang; Kung-Ch ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 109 KB

Covalently closed circular DNA (cccDNA) of hepatitis B virus (HBV) is difficult to eradicate using current antiviral therapy. This study compares cccDNA reduction with relation to liver histology in nucleoside/nucleotide-naฤฑ ยจve chronic hepatitis B patients receiving oral antiviral monotherapy (n ยผ